247
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Diagnostic Value of Neutrophil Lymphocyte Ratio and D-Dimer as Biological Markers of Deep Vein Thrombosis in Patients Presenting with Unilateral Limb Edema

ORCID Icon, , , , , , & ORCID Icon show all
Pages 313-325 | Published online: 20 May 2021

References

  • Wells P, Anderson D. The diagnosis and treatment of venous thromboembolism. Hematology Am Soc Hematol Educ Program. 2013;2013:457–463.
  • Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4suppl):S495–501. doi:10.1016/j.amepre.2009.12.017
  • Beyth J, Cohen AM, Landefeld CS. Long-term outcomes of deep-vein thrombosis. Arch Intern Med. 1995;155:1031–1037. doi:10.1001/archinte.1995.00430100053006
  • Le Gal G, Righini M. Controversies in the diagnosis of venous thromboembolism. J Thromb Haemost. 2015;13(S1):S259–65. doi:10.1111/jth.12937
  • Lesmana A, Pratama D, Wangge G. Comparison of wells score, D–dimer and combination of wells score and D–dimer with venous duplex ultrasonography in diagnosis of acute deep vein thrombosis in lower extremity andy. New Ropanasuri J Surg. 2017;2(1):e103–e109. doi:10.7454/nrjs.v2i1.17
  • Tan S, Chong B, Thoo F, Ho J, Boey H. Diagnosis of deep vein thrombosis: accuracy of colour Doppler ultrasound compared with venography. Singapore Med J. 1995;36:362–366.
  • Lewiss RE, Kaban NL, Saul T. Point-of-care ultrasound for a deep venous thrombosis. Glob Heart. 2013;8(4):329–333. doi:10.1016/j.gheart.2013.11.002
  • Mazzolai L, Aboyans V, Ageno W, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J. 2018;39(47):4208–4218. doi:10.1093/eurheartj/ehx003
  • Bogavac-Stanojević N, Dopsaj V, Jelić-Ivanović Z, Lakić D, Vasić D, Petrova G. Economic evaluation of different screening alternatives for patients with clinically suspected acute deep vein thrombosis. Biochem Medica. 2013;23(1):96–106. doi:10.11613/BM.2013.012
  • Huisman MV, Klok FA. Diagnostic management of acute deep vein thrombosis and pulmonary embolism. J Thromb Haemost. 2013;11(3):412–422. doi:10.1111/jth.12124
  • Geersing GJ, Zuithoff NPA, Kearon C, et al. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ. 2014;348(g1340):1–13. doi:10.1136/bmj.g1340
  • Ahearn GS, Bounameaux H. The role of the D-dimer in the diagnosis of venous thromboembolism. Semin Respir Crit Care Med. 2000;21(6):521–536. doi:10.1055/s-2000-13186
  • Bakirci EM, Topcu S, Kalkan K, et al. The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism. Clin Appl Thromb. 2015;21(2):181–185. doi:10.1177/1076029613494469
  • Chopra N, Doddamreddy P, Grewal H, Kumar PC. An elevated D-dimer value: a burden on our patients and hospitals. Int J Gen Med. 2012;25(5):87–92. doi:10.2147/IJGM.S25027
  • Bounds EJ, Kok SJ, Dimer D. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. Available from http://www.ncbi.nlm.nih.gov/books/NBK431064/. Accessed April 7, 2021.
  • Linkins L-A, Takach Lapner S. Review of D-dimer testing: good, bad, and ugly. Int J Lab Hematol. 2017;39(Suppl 1):98–103. doi:10.1111/ijlh.12665
  • Branchford BR, Carpenter SL. The role of inflammation in venous thromboembolism. Front Pediatr. 2018;6(May):142. doi:10.3389/fped.2018.00142
  • Christiansen SC, Nass IA, Cannegieter SC, Hammerstrom J, Rosendaal FR, Reitsma PH. Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Med. 2006;3(8):1414–1419. doi:10.1371/journal.pmed.0030334
  • Dowling NF, Hooper WC, Austin H. Understanding and predicting venous thromboembolism: the role of coagulation factors and inflammatory markers. Am J Med. 2002;113(8):689–690. doi:10.1016/S0002-9343(02)01395-5
  • Sharma K, Patel AK, Shah KH, Konat A. Is neutrophil-to-lymphocyte ratio a predictor of coronary artery disease in Western Indians? Int J Inflamm. 2017;2017:1–8. doi:10.1155/2017/4136126
  • Köse N, Yıldırım T, Akın F, Yıldırım SE, Altun İ. Prognostic role of NLR, PLR, and LMR in patients with pulmonary embolism. Bosn J Basic Med Sci. 2020;20(2):248–253. doi:10.17305/bjbms.2019.4445
  • Farah R, Nseir W, Kagansky D, et al. The role of neutrophil-lymphocyte ratio, and mean platelet volume in detecting patients with acute venous thromboembolism. J Clin Lab Anal. 2019;34(1):e23010. doi:10.1002/jcla.23010
  • Phan T, Brailovsky Y, Fareed J, Hoppensteadt D, Iqbal O, Darki A. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict all-cause mortality in acute pulmonary embolism. Clin Appl Thromb. 2020;Jan(26):1076029619900549.
  • Du P. Neutrophil-lymphocyte ratio is a predictor of venous thromboembolism in gastric cancer patients. Clin Lab. 2019;65(5). doi:10.7754/Clin.Lab.2018.181005
  • Go SI, Lee A, Lee US, et al. Clinical significance of the neutrophil–lymphocyte ratio in venous thromboembolism patients with lung cancer. Lung Cancer. 2014;84(1):79–85. doi:10.1016/j.lungcan.2014.01.014
  • Borazan E, Balik AA, Bozdaǧ Z, et al. Assessment of the relationship between neutrophil lymphocyte ratio and prognostic factors in non-metastatic colorectal cancer. Turk J Surg. 2017;33(3):185–189. doi:10.5152/turkjsurg.2017.3528
  • Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18(2):134–147. doi:10.1038/nri.2017.105
  • Pfeiler S, Stark K, Massberg S, Engelmann B. Propagation of thrombosis by neutrophils and extracellular nucleosome networks. Haematologica. 2017;102(2):206–213. doi:10.3324/haematol.2016.142471
  • Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44(2):62–69. doi:10.1053/j.seminhematol.2007.02.004
  • von Brühl M-L, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209(4):819–835. doi:10.1084/jem.20112322
  • Michel J, Ho-tin-noé B. Thrombi and neutrophils. Circ Res. 2015;116:1107–1109. doi:10.1161/CIRCRESAHA.115.306050
  • Cavuş UY, Yildirim S, Sönmez E, Ertan C, Ozeke O. Prognostic value of neutrophil/lymphocyte ratio in patients with pulmonary embolism. Turk J Med Sci. 2014;44(1):50–55. doi:10.3906/sag-1302-47
  • Aue G, Lozier JN, Tian X, et al. Inflammation, TNFα, and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia. Am J Hematol. 2011;86(10):835–840. doi:10.1002/ajh.22114
  • Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta. 2008;395:27–31. doi:10.1016/j.cca.2008.04.019
  • Ferroni P, Riondino S, Formica V, et al. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio. Int J Cancer. 2015;136(5):1234–1240. doi:10.1002/ijc.29076
  • Imtiaz F, Shafique K, Mirza S, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 2012;5:2. doi:10.1186/1755-7682-5-2
  • Ertaş G, Sönmez O, Turfan M, et al. Neutrophil/lymphocyte ratio is associated with thromboembolic stroke in patients with non-valvular atrial fibrillation. J Neurol Sci. 2013;324(1–2):49–52. doi:10.1016/j.jns.2012.09.032
  • Binnetoğlu E, Şengül E, Halhallı G, Dindar S, Şen H. Is neutrophil lymphocyte ratio an indicator for proteinuria in chronic kidney disease? J Clin Lab Anal. 2014;28(6):487–492. doi:10.1002/jcla.21715